Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes

Guidelines advise initial therapy with corticosteroids (CSs) in patients with presumed primary focal segmental glomerular sclerosis (pFSGS). Many patients do not achieve complete remission (CR) after 8 or 16 weeks. Although these patients are considered steroid resistant, clinical outcomes are ill d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney international reports 2022-01, Vol.7 (1), p.87-98
Hauptverfasser:	Rood, Ilse M., Bavinck, Aernoud, Lipska-Ziętkiewicz, Beata S., Lugtenberg, Dorien, Schaefer, Franz, Deegens, Jeroen K.J., Wetzels, Jack F.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Research corticosteroids focal segmental glomerulosclerosis nephrotic syndrome steroid resistant nephrotic syndrome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!